Patents by Inventor Doug Dolginow
Doug Dolginow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12258635Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: GrantFiled: January 22, 2024Date of Patent: March 25, 2025Assignee: Aqtual, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Patent number: 12241127Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: GrantFiled: January 22, 2024Date of Patent: March 4, 2025Assignee: Aqtual, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Patent number: 12241129Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: GrantFiled: December 8, 2023Date of Patent: March 4, 2025Assignee: Aqtual, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Patent number: 12209288Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: GrantFiled: July 21, 2023Date of Patent: January 28, 2025Assignee: Aqtual, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Patent number: 12018336Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: GrantFiled: July 21, 2023Date of Patent: June 25, 2024Assignee: Aqtual, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20240158867Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: January 22, 2024Publication date: May 16, 2024Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20240158868Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: January 22, 2024Publication date: May 16, 2024Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Patent number: 11965211Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: GrantFiled: October 8, 2018Date of Patent: April 23, 2024Assignee: Aqtual, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20240102109Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: December 8, 2023Publication date: March 28, 2024Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20230407408Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: July 21, 2023Publication date: December 21, 2023Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20230357864Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: July 21, 2023Publication date: November 9, 2023Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20190271044Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: October 8, 2018Publication date: September 5, 2019Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20160362749Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: June 15, 2016Publication date: December 15, 2016Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20160122830Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: October 28, 2015Publication date: May 5, 2016Inventors: Dietrich STEPHAN, Vern NORVIEL, Janet WARRINGTON, Doug DOLGINOW
-
Publication number: 20160115554Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: October 29, 2015Publication date: April 28, 2016Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20160115553Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: October 28, 2015Publication date: April 28, 2016Inventors: Dietrich STEPHAN, Vern NORVIEL, Janet WARRINGTON, Doug DOLGINOW
-
Publication number: 20140141426Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: November 8, 2013Publication date: May 22, 2014Applicant: Aueon, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20140141980Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: November 8, 2013Publication date: May 22, 2014Applicant: Aueon, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Publication number: 20140080733Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: ApplicationFiled: September 13, 2013Publication date: March 20, 2014Applicant: Aueon, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
-
Patent number: 8583380Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.Type: GrantFiled: September 4, 2009Date of Patent: November 12, 2013Assignee: Aueon, Inc.Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow
